Whether for drug screening or toxicity testing, stem cell-based 3D tissue models are key to biomedical research. However, producing cell aggregates in bioreactors is highly complex and cost-intensive.

A new in-plate, zero-disruption design enables reproducible organoid culture, downstream processing, and high-resolution imaging in a single 3D cell culture plate MONMOUTH JUNCTION, N.J., Feb. 9, 2026 ...

Developing chemotherapy drugs against breast cancer is costly, slow, and often inefficient, with more than 95% of screened drug candidates failing in patient trials. A new technique for 3D cell ...

The CellTiter-Glo ® 3D Cell Viability Assay is tailored to assess cell viability within 3D microtissue spheroids. Its reagent effectively permeates large spheroids and possesses enhanced lytic ...

3D bioprinting, in which living tissues are printed with cells mixed into soft hydrogels, or "bio-inks," is widely used in ...

Over the past two decades, researchers have learned that DNA inside the cell nucleus naturally folds into a network of ...

New ready-to-use kit combines Pluristyx’s high-quality pluripotent cells and mRNA technology with Solesis’ proprietary transfection technology to achieve nearly 100% transfection efficiency and exogen ...

3D cell cultures are no longer a futuristic idea. They’re already reshaping how we study diseases like cancer, offering more realistic models of how cells behave in the body. But despite their ...

An international research team claims to have achieved optimal passivation in inverted perovskite solar cells by applying thin layers of low-dimensional perovskite on top of a 3D perovskite film. The ...